Filed: 11/14/2023ACC: 0001420506-23-002080
📋 What this filing means
GHOST TREE CAPITAL, LLC filed this quarterly 13F‑HR report disclosing 63 equity positions with a total reported market value of $304.07M. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
63
Positions
$304.07M
Total AUM (reported)
15.63M
Total Shares
Allocation by class
COM$214.54M70.6%
CLASS A ORD$33.06M10.9%
S&P BIOTECH$21.91M7.2%
SPONSORED ADS$13.74M4.5%
SPONSORED ADR$9.19M3.0%
COM NEW$5.25M1.7%
COM SHS$4.19M1.4%
Portfolio Concentration
Top 3$78.00M25.7%
4–10$68.40M22.5%
11–25$86.49M28.4%
Rest$71.18M23.4%
Top 3 weight
25.7%
Top 10 weight
48.1%
Voting Authority Distribution
Total shares with voting rights: 15.63M
Sole
Full voting authority
15.63M
shares
% of voting shares100.0%
Shared
Joint voting authority
0.00
shares
% of voting shares0.0%
None
No voting authority
0.00
shares
% of voting shares0.0%
Investment Discretion (by position count)
Sole63
Shared0
Other0
Dominant voting typeSole · 100.0% of voting shares
Institutional Holdings63
Rows:
MOONLAKE IMMUNOTHERAPEUTICS
SOLEShares580K
TypeSH
Market value$33.06M
10.87%
Sole
580K
Shared
0.00
None
0.00
SAREPTA THERAPEUTICS INC
SOLEShares190K
TypeSH
Market value$23.03M
7.57%
Sole
190K
Shared
0.00
None
0.00
SPDR SER TR
SOLEShares300K
TypeSH
Market value$21.91M
7.20%
Sole
300K
Shared
0.00
None
0.00
AKERO THERAPEUTICS INC
SOLEShares365K
TypeSH
Market value$18.46M
6.07%
Sole
365K
Shared
0.00
None
0.00
KRYSTAL BIOTECH INC
SOLEShares80K
TypeSH
Market value$9.28M
3.05%
Sole
80K
Shared
0.00
None
0.00
MADRIGAL PHARMACEUTICALS INC
SOLEShares57.50K
TypeSH
Market value$8.40M
2.76%
Sole
57.50K
Shared
0.00
None
0.00
TG THERAPEUTICS INC
SOLEShares1M
TypeSH
Market value$8.36M
2.75%
Sole
1M
Shared
0.00
None
0.00
IMMUNOVANT INC
SOLEShares215K
TypeSH
Market value$8.25M
2.71%
Sole
215K
Shared
0.00
None
0.00
ASCENDIS PHARMA A/S
SOLEShares85K
TypeSH
Market value$7.96M
2.62%
Sole
85K
Shared
0.00
None
0.00
AXSOME THERAPEUTICS INC
SOLEShares110K
TypeSH
Market value$7.69M
2.53%
Sole
110K
Shared
0.00
None
0.00
ALPINE IMMUNE SCIENCES INC
SOLEShares664.13K
TypeSH
Market value$7.60M
2.50%
Sole
664.13K
Shared
0.00
None
0.00
SYNDAX PHARMACEUTICALS INC
SOLEShares500K
TypeSH
Market value$7.26M
2.39%
Sole
500K
Shared
0.00
None
0.00
VAXCYTE INC
SOLEShares140K
TypeSH
Market value$7.14M
2.35%
Sole
140K
Shared
0.00
None
0.00
TARSUS PHARMACEUTICALS INC
SOLEShares400K
TypeSH
Market value$7.11M
2.34%
Sole
400K
Shared
0.00
None
0.00
APELLIS PHARMACEUTICALS INC
SOLEShares185K
TypeSH
Market value$7.04M
2.31%
Sole
185K
Shared
0.00
None
0.00
PROTAGONIST THERAPEUTICS INC
SOLEShares400K
TypeSH
Market value$6.67M
2.19%
Sole
400K
Shared
0.00
None
0.00
COGENT BIOSCIENCES INC
SOLEShares650K
TypeSH
Market value$6.34M
2.08%
Sole
650K
Shared
0.00
None
0.00
ROCKET PHARMACEUTICALS INC
SOLEShares295K
TypeSH
Market value$6.04M
1.99%
Sole
295K
Shared
0.00
None
0.00
AMBRX BIOPHARMA INC
SOLEShares525K
TypeSH
Market value$6.04M
1.99%
Sole
525K
Shared
0.00
None
0.00
PMV PHARMACEUTICALS INC
SOLEShares705.88K
TypeSH
Market value$4.33M
1.43%
Sole
705.88K
Shared
0.00
None
0.00
REPLIMUNE GROUP INC
SOLEShares250K
TypeSH
Market value$4.28M
1.41%
Sole
250K
Shared
0.00
None
0.00
VIRIDIAN THERAPEUTICS INC
SOLEShares275K
TypeSH
Market value$4.22M
1.39%
Sole
275K
Shared
0.00
None
0.00
TAYSHA GENE THERAPIES INC
SOLEShares1.32M
TypeSH
Market value$4.19M
1.38%
Sole
1.32M
Shared
0.00
None
0.00
DECIPHERA PHARMACEUTICALS IN
SOLEShares325K
TypeSH
Market value$4.13M
1.36%
Sole
325K
Shared
0.00
None
0.00
PHATHOM PHARMACEUTICALS INC
SOLEShares395K
TypeSH
Market value$4.10M
1.35%
Sole
395K
Shared
0.00
None
0.00
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
MOONLAKE IMMUNOTHERAPEUTICSSOLE | CLASS A ORD | 580K | SH | $33.06M 10.87% | 580K | 0.00 | 0.00 |
SAREPTA THERAPEUTICS INCSOLE | COM | 190K | SH | $23.03M 7.57% | 190K | 0.00 | 0.00 |
SPDR SER TRSOLE | S&P BIOTECH | 300K | SH | $21.91M 7.20% | 300K | 0.00 | 0.00 |
AKERO THERAPEUTICS INCSOLE | COM | 365K | SH | $18.46M 6.07% | 365K | 0.00 | 0.00 |
KRYSTAL BIOTECH INCSOLE | COM | 80K | SH | $9.28M 3.05% | 80K | 0.00 | 0.00 |
MADRIGAL PHARMACEUTICALS INCSOLE | COM | 57.50K | SH | $8.40M 2.76% | 57.50K | 0.00 | 0.00 |
TG THERAPEUTICS INCSOLE | COM | 1M | SH | $8.36M 2.75% | 1M | 0.00 | 0.00 |
IMMUNOVANT INCSOLE | COM | 215K | SH | $8.25M 2.71% | 215K | 0.00 | 0.00 |
ASCENDIS PHARMA A/SSOLE | SPONSORED ADR | 85K | SH | $7.96M 2.62% | 85K | 0.00 | 0.00 |
AXSOME THERAPEUTICS INCSOLE | COM | 110K | SH | $7.69M 2.53% | 110K | 0.00 | 0.00 |
ALPINE IMMUNE SCIENCES INCSOLE | COM | 664.13K | SH | $7.60M 2.50% | 664.13K | 0.00 | 0.00 |
SYNDAX PHARMACEUTICALS INCSOLE | COM | 500K | SH | $7.26M 2.39% | 500K | 0.00 | 0.00 |
VAXCYTE INCSOLE | COM | 140K | SH | $7.14M 2.35% | 140K | 0.00 | 0.00 |
TARSUS PHARMACEUTICALS INCSOLE | COM | 400K | SH | $7.11M 2.34% | 400K | 0.00 | 0.00 |
APELLIS PHARMACEUTICALS INCSOLE | COM | 185K | SH | $7.04M 2.31% | 185K | 0.00 | 0.00 |
PROTAGONIST THERAPEUTICS INCSOLE | COM | 400K | SH | $6.67M 2.19% | 400K | 0.00 | 0.00 |
COGENT BIOSCIENCES INCSOLE | COM | 650K | SH | $6.34M 2.08% | 650K | 0.00 | 0.00 |
ROCKET PHARMACEUTICALS INCSOLE | COM | 295K | SH | $6.04M 1.99% | 295K | 0.00 | 0.00 |
AMBRX BIOPHARMA INCSOLE | SPONSORED ADS | 525K | SH | $6.04M 1.99% | 525K | 0.00 | 0.00 |
PMV PHARMACEUTICALS INCSOLE | COM | 705.88K | SH | $4.33M 1.43% | 705.88K | 0.00 | 0.00 |
REPLIMUNE GROUP INCSOLE | COM | 250K | SH | $4.28M 1.41% | 250K | 0.00 | 0.00 |
VIRIDIAN THERAPEUTICS INCSOLE | COM | 275K | SH | $4.22M 1.39% | 275K | 0.00 | 0.00 |
TAYSHA GENE THERAPIES INCSOLE | COM SHS | 1.32M | SH | $4.19M 1.38% | 1.32M | 0.00 | 0.00 |
DECIPHERA PHARMACEUTICALS INSOLE | COM | 325K | SH | $4.13M 1.36% | 325K | 0.00 | 0.00 |
PHATHOM PHARMACEUTICALS INCSOLE | COM | 395K | SH | $4.10M 1.35% | 395K | 0.00 | 0.00 |
Page 1 of 3